or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    MFG A 2.55 2.33
    ABBV F 0.61 2.05
    E F 0.59 1.45
    TM F 0.40 0.29
    NVS D 0.45 0.27
    HMC F 0.19 0.25

    Represented by ETF Holdings

    Keywords: Automotive Industry Cars Eye Care Products Passenger Car Pharmaceutical Transport Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Advisory Services Anemia Animal Health Antibiotics Asset And Liability Management Asset Management Asset Management Services Atopic Dermatitis Auto Parts Autoimmune Disease Bank
    Industries: Auto Manufacturers Drug Manufacturers - Major Banks - Regional - Asia Oil & Gas Integrated

    Recent News for John Hancock International High Dividend ETF & its Holdings

    Date Stock Title
    Nov 21 TM Experts: These 5 Car Brands Are the Cheapest To Maintain
    Nov 21 TM Toyota Releases 2024 North American Environmental Sustainability Report
    Nov 21 HMC Honda hopes to double EV driving range with solid-state batteries, R&D chief says
    Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
    Nov 20 TM Toyota Plunges 20% in 6 Months: At a Low P/E, is TM Stock a Buy Now?
    Nov 20 HMC Toyota Plunges 20% in 6 Months: At a Low P/E, is TM Stock a Buy Now?
    Nov 19 TM Toyota to launch next generation Camry in India next month
    Nov 19 ABBV Where Will AbbVie Be in 5 Years?
    Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
    Nov 19 TM Wall Street Analysts See Toyota Motor (TM) as a Buy: Should You Invest?
    Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
    Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
    Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
    Nov 19 TM Toyota to begin testing hydrogen-electric hybrid vans in 2025
    Nov 19 TM Philippine vehicle sales growth continues in October
    Nov 19 ABBV RVPH: Year-End OLE Update
    Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
    Nov 18 ABBV AbbVie snaps eight straight sessions of losses
    Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
    Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
    John Hancock Exchange-Traded Fund Trust - John Hancock International High Dividend ETF is an exchange traded fund launched and managed by John Hancock Investment Management LLC. The fund is co-managed by Manulife Investment Management (US) LLC. It invests in public equity markets of global ex-US region. The fund invests in stocks of companies operating across diversified sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund employs proprietary research to create its portfolio. Traded Fund Trust - John Hancock International High Dividend ETF was formed in December 20, 2022 and is domiciled in United States.
    Exchange Traded Funds SPDR
    Back to the Main JHID Page...